FACTORS ASSOCIATED WITH PRESCRIBING OF TERIFLUNOMIDE AND DIMETHYL FUMARATE VERSUS FINGOLIMOD IN MULTIPLE SCLEROSIS

被引：0
|
作者：
Earla, J. r [1 ]
Hutton, G. J. [2 ]
Aparasu, R. R. [3 ]
机构：
[1] Univ Houston, Coll Pharm, Fords, NJ USA
[2] Baylor Coll Med, McNair Campus, Houston, TX 77030 USA
[3] Univ Houston, Coll Pharm, Houston, TX 77030 USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HSD13
引用
收藏
页码：S482 / S482
页数：1
相关论文
共 50 条
  • [31] Comparative analysis of fingolimod versus teriflunomide in relapsing-remitting multiple sclerosis
    Boz, Cavit
    Terzi, Murat
    Ozer, Bilge
    Turkoglu, Recai
    Karabudak, Rana
    Efendi, Husnu
    Soysal, Aysun
    Sevim, Serhan
    Altintas, Ayse
    Kurne, Asli
    Akcali, Aylin
    Akman, Gulsen
    Yuceyar, Nur
    Balci, Belgin Petek
    Ekmekci, Ozgul
    Karahan, Serap Zengin
    Demirkiran, Meltem
    Altunrende, Burcu
    Turan, Omer Faruk
    GozubatikCelik, Gokcen
    Kale, Nilufer
    Koseoglu, Mesrure
    Ozakbas, Serkan
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 36
  • [32] The real-world patient experience of fingolimod and dimethyl fumarate for multiple sclerosis
    Wicks P.
    Rasouliyan L.
    Katic B.
    Nafees B.
    Flood E.
    Sasané R.
    BMC Research Notes, 9 (1)
  • [33] Comparative analysis of dimethyl fumarate and fingolimod in relapsing-remitting multiple sclerosis
    Lorscheider, Johannes
    Benkert, Pascal
    Lienert, Carmen
    Haenni, Peter
    Derfuss, Tobias
    Kuhle, Jens
    Kappos, Ludwig
    Yaldizli, Oezguer
    JOURNAL OF NEUROLOGY, 2021, 268 (03) : 941 - 949
  • [34] Comparison of fingolimod and dimethyl fumarate in the treatment of multiple sclerosis: one year experience
    Vollmer, B. L.
    Nair, K.
    Sillau, S. H.
    Strobel, M.
    Robinson, L.
    Corboy, J.
    Vollmer, T.
    Alvarez, E.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 536 - 536
  • [35] Factors associated with dimethyl fumarate induced lymphopenia in a rural multiple sclerosis cohort
    Malik, M. T.
    Zhang, Y.
    Lee, M.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 572 - 572
  • [36] Alopecia associated with dimethyl fumarate treatment for multiple sclerosis
    Ana Abičić
    Ivan Adamec
    Mario Habek
    Wiener Medizinische Wochenschrift, 2023, 173 : 287 - 289
  • [37] Alopecia associated with dimethyl fumarate treatment for multiple sclerosis
    Abicic, Ana
    Adamec, Ivan
    Habek, Mario
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2023, 173 (11-12) : 287 - 289
  • [38] Effect of smoking on disease activity in multiple sclerosis patients treated with dimethyl fumarate or fingolimod
    Tanaka, Eizo
    Watanabe, Mitsuru
    Fukumoto, Shoko
    Masaki, Katsuhisa
    Yamasaki, Ryo
    Matsushita, Takuya
    Isobe, Noriko
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 70
  • [39] Dimethyl fumarate for multiple sclerosis
    Xu, Zhu
    Zhang, Feng
    Sun, FangLi
    Gu, KeFeng
    Dong, Shuai
    He, Dian
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (04):
  • [40] Comparison of Dimethyl Fumarate vs Fingolimod and Rituximab vs Natalizumab for Treatment of Multiple Sclerosis
    Hou, Jue
    Kim, Nicole
    Cai, Tianrun
    Dahal, Kumar
    Weiner, Howard
    Chitnis, Tanuja
    Cai, Tianxi
    Xia, Zongqi
    JAMA NETWORK OPEN, 2021, 4 (11) : E2134627
12345